Acadian Asset Management LLC Acquires 286,074 Shares of Zoetis Inc. $ZTS

Acadian Asset Management LLC increased its stake in shares of Zoetis Inc. (NYSE:ZTS) by 259.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 396,481 shares of the company’s stock after acquiring an additional 286,074 shares during the quarter. Acadian Asset Management LLC owned about 0.09% of Zoetis worth $61,822,000 at the end of the most recent quarter.

Several other hedge funds have also recently made changes to their positions in the business. Savvy Advisors Inc. lifted its position in shares of Zoetis by 54.0% in the 2nd quarter. Savvy Advisors Inc. now owns 3,177 shares of the company’s stock worth $495,000 after purchasing an additional 1,114 shares during the period. Sound Income Strategies LLC raised its stake in shares of Zoetis by 54.3% in the second quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock worth $67,000 after purchasing an additional 152 shares during the last quarter. Canoe Financial LP boosted its holdings in shares of Zoetis by 859.0% in the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock valued at $2,085,000 after acquiring an additional 11,975 shares during the last quarter. Strs Ohio acquired a new position in Zoetis in the first quarter valued at approximately $22,891,000. Finally, Soros Capital Management LLC grew its position in shares of Zoetis by 32.0% during the 1st quarter. Soros Capital Management LLC now owns 17,441 shares of the company’s stock valued at $2,872,000 after acquiring an additional 4,230 shares during the period. 92.80% of the stock is currently owned by hedge funds and other institutional investors.

Zoetis Trading Up 0.5%

Shares of Zoetis stock opened at $120.20 on Monday. Zoetis Inc. has a fifty-two week low of $117.26 and a fifty-two week high of $181.85. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. The business’s fifty day moving average is $144.21 and its two-hundred day moving average is $152.63. The firm has a market cap of $52.97 billion, a PE ratio of 20.69, a P/E/G ratio of 2.31 and a beta of 0.90.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same quarter in the previous year, the firm posted $1.58 earnings per share. The firm’s quarterly revenue was up .5% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts anticipate that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date is Friday, October 31st. Zoetis’s payout ratio is currently 33.67%.

Analyst Upgrades and Downgrades

ZTS has been the topic of several research analyst reports. Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Leerink Partners lowered Zoetis from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. JPMorgan Chase & Co. lowered their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Finally, UBS Group dropped their target price on Zoetis from $158.00 to $141.00 and set a “neutral” rating on the stock in a report on Wednesday, November 5th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $191.00.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.